ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Gastroenterology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,398Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 187

$1.19M Total Retail Price of All Prescriptions

Rank: 1 out of 187

834 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 834 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

9% of this provider’s 834 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

1% of this provider’s 17,254 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 40%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $146 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 6.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
FUROSEMIDE 735 722 1 11
SIMVASTATIN 697 647 2 6
OMEPRAZOLE 576 516 3 1
LEVOTHYROXINE SODIUM 568 553 4 9
LISINOPRIL 556 511 5 13
WARFARIN SODIUM 519 513 6 12
METOPROLOL TARTRATE 503 498 7 17
DONEPEZIL HCL 497 496 8 19
MIRTAZAPINE 447 443 9 26
AMLODIPINE BESYLATE 401 390 10 8
POTASSIUM CHLORIDE 389 383 11 27
ESCITALOPRAM OXALATE 368 347 12 30
ATORVASTATIN CALCIUM 331 305 13 14
NAMENDA 297 297 14 35
METOPROLOL SUCCINATE 234 210 15 24
CARBIDOPA-LEVODOPA 211 211 16 50
ZOLPIDEM TARTRATE 203 174 17 34
METFORMIN HCL 200 173 18 22
HYDROCHLOROTHIAZIDE 197 177 19 23
HYDROCODONE-ACETAMINOPHEN 190 175 S3 20 43
TRAZODONE HCL 186 177 21 31
PRAVASTATIN SODIUM 182 176 22 37
CITALOPRAM HBR 175 171 23 39
CLOPIDOGREL 175 159 23 56
RISPERIDONE 154 154 25 40
LEXAPRO 149 147 26 77
GABAPENTIN 149 147 26 47
TAMSULOSIN HCL 148 139 28 51
SERTRALINE HCL 142 132 29 32
NEXIUM 142 123 29 2
AZITHROMYCIN 140 118 31 79
PLAVIX 131 125 32 83
ATENOLOL 131 131 32 29
ADVAIR DISKUS 128 123 34 58
LOSARTAN POTASSIUM 127 123 35 67
PREDNISONE 127 126 35 49
SPIRIVA 126 126 37 64
ALENDRONATE SODIUM 123 117 38 41
DIOVAN 114 108 39 48
LANTUS 112 111 40 52
ALLOPURINOL 111 109 41 54
RANITIDINE HCL 102 98 42 5
IPRATROPIUM-ALBUTEROL 99 99 43 69
OXYCODONE-ACETAMINOPHEN 96 94 S2 44 76
CYMBALTA 96 73 44 53
EXELON 88 88 46 70
PHENYTOIN SODIUM EXTENDED 87 80 47 99
GLIPIZIDE 86 86 48 59
LIPITOR 86 82 48 100
CRESTOR 82 69 50 46
JANUVIA 82 65 50 103
DILTIAZEM 24HR CD 82 82 50 78
PAROXETINE HCL 80 72 53 82
PROPRANOLOL HCL 77 62 54 106
GLYBURIDE 71 71 R 55 111
ISOSORBIDE MONONITRATE ER 70 70 56 61
ZETIA 69 62 57 66
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 60 57 62
GLIMEPIRIDE 68 50 59 81
LABETALOL HCL 68 59 59 116
BENICAR 67 67 61 117
NYSTOP 67 67 61 117
NOVOLOG 67 67 61 88
OXYBUTYNIN CHLORIDE ER 64 64 64 63
DEXILANT 60 57 65 4
METFORMIN HCL ER 60 51 65 126
VERAPAMIL ER 60 57 65 126
LEVOFLOXACIN 59 54 68 128
PANTOPRAZOLE SODIUM 59 41 68 3
LOVASTATIN 59 52 68 89
KLOR-CON M20 58 44 71 130
VYTORIN 56 55 72 133
CIPROFLOXACIN HCL 54 51 73 138
ABILIFY 53 52 74 74
SYNTHROID 53 44 74 92
SEROQUEL 53 53 74 85
BRIMONIDINE TARTRATE 52 52 77 139
CARVEDILOL 52 52 77 68
PROCHLORPERAZINE MALEATE 52 49 77 139
LACTULOSE 51 51 80 93
FENTANYL 51 47 S2 80 60
AMLODIPINE BESYLATE-BENAZEPRIL 51 47 80 142
GLIPIZIDE XL 50 50 83 144
POLYETHYLENE GLYCOL 3350 50 49 83 7
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 20, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.